{
    "title": "U.S. health regulator extends review of Biogen's ALS drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11323691/U-S-health-regulator-extends-review-Biogens-ALS-drug.html",
    "date": "2022-10-17",
    "keywords": [
        "drug",
        "biogen",
        "approval",
        "review",
        "agency",
        "year",
        "tofersen",
        "disease",
        "food",
        "administration",
        "treatment",
        "form",
        "sclerosis",
        "company",
        "monday",
        "information",
        "time",
        "target",
        "action",
        "date",
        "april",
        "application",
        "pathway",
        "july",
        "decision",
        "jan",
        "goal",
        "latestage",
        "study",
        "improvement",
        "status",
        "month",
        "analysis",
        "longerterm",
        "use",
        "initiation",
        "progression",
        "lou",
        "brain",
        "cord",
        "paralysis",
        "death",
        "cause",
        "gene",
        "accumulation",
        "protein",
        "sod1",
        "reporting",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "syamnath",
        "savio",
        "dsouza"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}